Trademark: 85540626
Word
ADNEXUS
Status
Dead
Status Code
606
Status Date
Monday, August 5, 2013
Serial Number
85540626
Mark Type
4000
Filing Date
Monday, February 13, 2012
Published for Opposition
Tuesday, May 8, 2012
Abandoned Date
Monday, August 5, 2013
Trademark Owner History
Adnexus, a Bristol-Myers Squibb R&D Company - Owner At Publication
Classifications
5 Biotechnology and pharmaceutical products, namely, therapeutic proteins for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
Trademark Events
Aug 5, 2013
Abandonment Notice Mailed - No Use Statement Filed
Aug 5, 2013
Abandonment - No Use Statement Filed
Mar 12, 2013
Teas Change Of Correspondence Received
Dec 29, 2012
Notice Of Approval Of Extension Request E-Mailed
Dec 27, 2012
Extension 1 Granted
Dec 27, 2012
Extension 1 Filed
Dec 27, 2012
Teas Extension Received
Jul 3, 2012
Noa E-Mailed - Sou Required From Applicant
May 8, 2012
Official Gazette Publication Confirmation E-Mailed
May 8, 2012
Published For Opposition
Apr 18, 2012
Notification Of Notice Of Publication E-Mailed
Mar 31, 2012
Law Office Publication Review Completed
Mar 31, 2012
Assigned To Lie
Mar 13, 2012
Approved For Pub - Principal Register
Mar 9, 2012
Assigned To Examiner
Feb 21, 2012
New Application Office Supplied Data Entered In Tram
Feb 16, 2012
New Application Entered In Tram
FIRST CITIZENS SIGNATURE RETIREMENT SOLUTION
SMARTLINE
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov